🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective and retrospective cohort study of about five years will be pe...
Status
Recruiting
Location
IRCCS Neuromed
Start Date
2017-11-22
Trial ID
NCT03217396
Treatments Being Tested
The research study is being conducted to study whether performing injection...
Status
Not Yet Recruiting
Location
Abramson Cancer Center at the University of Pennsylvania
Start Date
2026-09-01
Trial ID
NCT07059611
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Start Date
2006-10
Trial ID
NCT00433433
Treatments Being Tested
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
The major purpose of this study is to evaluate the curative potential of wh...
Status
Completed
Location
Children's Healthcare of Atlanta/Emory University
Start Date
2003-07
Trial ID
NCT00231309
Treatments Being Tested
This is an open-label randomized phase II study. Patients are randomized so...
Status
Withdrawn
Location
University of California
Start Date
2015-06
Trial ID
NCT01530984
Treatments Being Tested
This phase Ib trials studies the side effects and how well talimogene laher...
Status
Completed
Location
University of California, San Francisco
Start Date
2020-02-05
Trial ID
NCT03554044
This study was a phase Ib study of the safety and pharmacokinetics/pharmaco...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2014-02-25
Trial ID
NCT02522234
Treatments Being Tested
Phase II trial to study the effectiveness of combination chemotherapy and p...
Status
Terminated
Location
Gynecologic Oncology Group
Start Date
1999-11
Trial ID
NCT00004221
Alemtuzumab is an anti CD52 monoclonal antibody. The CD52 antigen is presen...
Status
Completed
Location
Saint Antoine Hospital, Hematology Unit
Start Date
2006-10
Trial ID
NCT00773149
Treatments Being Tested